Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 20.85M | $1.21B | 14.40% | +4.36M | 2026-06-30 |
| Jupiter Topco LLC | 17.97M | $1.04B | 12.41% | -- | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 12.21M | $709.0M | 8.43% | +81.4K | 2026-06-30 |
| BlackRock, Inc. | 12.07M | $701.0M | 8.34% | +1.10M | 2026-06-30 |
| RA Capital Management, L.P. | 11.47M | $667.0M | 7.93% | -- | 2026-06-30 |
| Wellington Management Group LLP | 7.00M | $406.0M | 4.84% | +1.39M | 2026-06-30 |
| Vanguard Portfolio Management LLC | 6.59M | $383.0M | 4.55% | +314.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 6.35M | $369.0M | 4.38% | +82.0K | 2026-06-30 |
| State Street Corp | 5.35M | $311.0M | 3.70% | +911.2K | 2026-06-30 |
| Deep Track Capital, LP | 4.30M | $249.0M | 2.97% | -- | 2026-06-30 |
